Matthias Bros

7PUBLICATIONS
46CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor Cells.

Ramy Ashry, Mohamed Abdelsalam, Julia Hausen

|Apr 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.

Andreas O Mieland, Giuseppe Petrosino, Mario Dejung

|Nov 15, 2024
New insights for the development of efficient DNA vaccines.

Simone Berger, Yanira Zeyn, Ernst Wagner

|May 24, 2023
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer.

Natalie Fuchs, Mergim Meta, Bellinda Lantzberg

|Sep 26, 2022
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation.

Maria Isabel Fleischer, Nadine Röhrig, Verena K Raker

|Feb 10, 2018
Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells.

Limei Shen, Stefan Tenzer, Moritz Hess

Pageof 2

Frequent Collaborators

3 joint publications

Yanira Zeyn

2 joint publications

Oliver H Krämer

2 joint publications

Wolfgang Sippl

2 joint publications

Christoph Hieber